BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38318506)

  • 1. Canine diabetes mellitus demonstrates multiple markers of chronic inflammation including Th40 cell increases and elevated systemic-immune inflammation index, consistent with autoimmune dysregulation.
    Vaitaitis G; Webb T; Webb C; Sharkey C; Sharkey S; Waid D; Wagner DH
    Front Immunol; 2023; 14():1319947. PubMed ID: 38318506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An alternative role for Foxp3 as an effector T cell regulator controlled through CD40.
    Vaitaitis GM; Carter JR; Waid DM; Olmstead MH; Wagner DH
    J Immunol; 2013 Jul; 191(2):717-25. PubMed ID: 23776180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD40 expression and its association with low-grade inflammation in a Greek population of type 1 diabetic juveniles: evidence for differences in CD40 mRNA isoforms expressed by peripheral blood mononuclear cells.
    Chatzigeorgiou AE; Lembessis PE; Mylona-Karagianni CF; Tsouvalas EA; Diamanti-Kandarakis E; Kamper EF
    Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):38-46. PubMed ID: 19834879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining a new biomarker for the autoimmune component of Multiple Sclerosis: Th40 cells.
    Waid DM; Schreiner T; Vaitaitis G; Carter JR; Corboy JR; Wagner DH
    J Neuroimmunol; 2014 May; 270(1-2):75-85. PubMed ID: 24690203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells.
    Vaitaitis GM; Yussman MG; Waid DM; Wagner DH
    PLoS One; 2017; 12(2):e0172037. PubMed ID: 28192476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR2 and TLR4 expression on CD14(++) and CD14(+) monocyte subtypes in adult-onset autoimmune diabetes.
    Cejkova P; Nemeckova I; Broz J; Cerna M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):76-83. PubMed ID: 25942429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High distribution of CD40 and TRAF2 in Th40 T cell rafts leads to preferential survival of this auto-aggressive population in autoimmunity.
    Vaitaitis GM; Wagner DH
    PLoS One; 2008 Apr; 3(4):e2076. PubMed ID: 18446238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral blood mononuclear cells of patients with latent autoimmune diabetes secrete higher levels of pro- & anti-inflammatory cytokines compared to those with type-1 diabetes mellitus following
    Badal D; Kumar R; Paul M; Dayal D; Bhansali A; Bhadada SK; Kumar R; Sachdeva N
    Indian J Med Res; 2017 Jun; 145(6):767-776. PubMed ID: 29067979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic immune cell dysregulation and molecular subtypes revealed by single-cell RNA-seq of subjects with type 1 diabetes.
    Honardoost MA; Adinatha A; Schmidt F; Ranjan B; Ghaeidamini M; Arul Rayan N; Gek Liang Lim M; Joanito I; Xiao Xuan Lin Q; Rajagopalan D; Qi Mok S; Hwang YY; Larbi A; Khor CC; Foo R; Boehm BO; Prabhakar S
    Genome Med; 2024 Mar; 16(1):45. PubMed ID: 38539228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetes.
    Waid DM; Vaitaitis GM; Pennock ND; Wagner DH
    J Leukoc Biol; 2008 Aug; 84(2):431-9. PubMed ID: 18469093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased levels of inflammatory mediators and proinflammatory monocytes in patients with type I diabetes mellitus and nephropathy.
    Kolseth IB; Reine TM; Parker K; Sudworth A; Witczak BJ; Jenssen TG; Kolset SO
    J Diabetes Complications; 2017 Jan; 31(1):245-252. PubMed ID: 27452162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocrevus reduces TH40 cells, a biomarker of systemic inflammation, in relapsing multiple sclerosis (RMS) and in progressive multiple sclerosis (PMS).
    Curran C; Vaitaitis G; Waid D; Volmer T; Alverez E; Wagner DH
    J Neuroimmunol; 2023 Jan; 374():578008. PubMed ID: 36535240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune aspects of type 2 diabetes mellitus - a mini-review.
    Itariu BK; Stulnig TM
    Gerontology; 2014; 60(3):189-96. PubMed ID: 24457898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canine memory T-cell subsets in health and disease.
    Bauman AB; Moeller CE; Soileau AM; Goodermuth CE; Costa VR; Schaumburg JC; Pucheu-Haston CM; Welborn ND; Dehghanpir SD; Mitchell MA; Withers SS
    Vet Immunol Immunopathol; 2022 Apr; 246():110401. PubMed ID: 35255296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptome analysis of peripheral blood mononuclear cells in patients with type 1 diabetes mellitus.
    Wang Z; Zhang L; Tang F; Yang Z; Wang M; Jia J; Wang D; Yang L; Zhong S; Yuan G
    Endocrine; 2022 Nov; 78(2):270-279. PubMed ID: 35976509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of proinflammatory cytokine production in response to bacterial pathogen-associated molecular patterns in dogs with diabetes mellitus undergoing insulin therapy.
    DeClue AE; Nickell J; Chang CH; Honaker A
    J Diabetes Sci Technol; 2012 May; 6(3):496-502. PubMed ID: 22768879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-Regulatory Cell Subsets in Children with Type 1 Diabetes Mellitus: Relation to Control of the Disease.
    Ghonaim MM; El-Edel RH; Kamal Eldein SM; Abo El Fotoh WMM; Salman SS
    Endocr Metab Immune Disord Drug Targets; 2017; 17(3):238-245. PubMed ID: 28820075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum CXCL1 concentrations are elevated in type 1 diabetes mellitus, possibly reflecting activity of anti-islet autoimmune activity.
    Takahashi K; Ohara M; Sasai T; Homma H; Nagasawa K; Takahashi T; Yamashina M; Ishii M; Fujiwara F; Kajiwara T; Taneichi H; Takebe N; Satoh J
    Diabetes Metab Res Rev; 2011 Nov; 27(8):830-3. PubMed ID: 22069268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate immune stimulation of whole blood reveals IFN-1 hyper-responsiveness in type 1 diabetes.
    Rodrigues KB; Dufort MJ; Llibre A; Speake C; Rahman MJ; Bondet V; Quiel J; Linsley PS; Greenbaum CJ; Duffy D; Tarbell KV
    Diabetologia; 2020 Aug; 63(8):1576-1587. PubMed ID: 32500289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel subpopulation of monocytes with a strong interferon signature indicated by SIGLEC-1 is present in patients with in recent-onset type 1 diabetes.
    Guo M; Guo H; Zhu J; Wang F; Chen J; Wan C; Deng Y; Wang F; Xu L; Chen Y; Li R; Liu S; Zhang L; Wang Y; Zhou J; Li S
    Diabetologia; 2024 Apr; 67(4):623-640. PubMed ID: 38349399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.